Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DECIDE: Denosumab vs Alendronate in Postmenopausal Women with Low BMD
NCT00330460Phase 3Completed
- Sponsor
- Amgen
- Start
- May 2006
- Primary completion
- Nov 2007
01
Overview
A Phase 3 trial of denosumab in osteoporosis, osteopenia, sponsored by Amgen. Started May 2006; status: completed.
02
Drugs
denosumab
03
Conditions
osteoporosisosteopenia
Beyond the preview
Go deeper on NCT00330460.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00330460.